183 related articles for article (PubMed ID: 24982661)
41. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.
Jahrsdorfer B; Mühlenhoff L; Blackwell SE; Wagner M; Poeck H; Hartmann E; Jox R; Giese T; Emmerich B; Endres S; Weiner GJ; Hartmann G
Clin Cancer Res; 2005 Feb; 11(4):1490-9. PubMed ID: 15746051
[TBL] [Abstract][Full Text] [Related]
42. The Importance of an In-depth Study of Immunoglobulin Gene Rearrangements When Ascertaining the Clonal Relationship between Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma.
Trudel S; Ghamlouch H; Dremaux J; Delette C; Harrivel V; Marolleau JP; Gubler B
Front Immunol; 2016; 7():625. PubMed ID: 28082975
[TBL] [Abstract][Full Text] [Related]
43. The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism.
Pedersen IM; Buhl AM; Klausen P; Geisler CH; Jurlander J
Blood; 2002 Feb; 99(4):1314-9. PubMed ID: 11830481
[TBL] [Abstract][Full Text] [Related]
44. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
45. Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes.
Biagi E; Dotti G; Yvon E; Lee E; Pule M; Vigouroux S; Gottschalk S; Popat U; Rousseau R; Brenner M
Blood; 2005 Mar; 105(6):2436-42. PubMed ID: 15536147
[TBL] [Abstract][Full Text] [Related]
46. The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells.
Luqman M; Klabunde S; Lin K; Georgakis GV; Cherukuri A; Holash J; Goldbeck C; Xu X; Kadel EE; Lee SH; Aukerman SL; Jallal B; Aziz N; Weng WK; Wierda W; O'Brien S; Younes A
Blood; 2008 Aug; 112(3):711-20. PubMed ID: 18497318
[TBL] [Abstract][Full Text] [Related]
47. Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia.
Friedman DF; Moore JS; Erikson J; Manz J; Goldman J; Nowell PC; Silberstein LE
Blood; 1992 Nov; 80(9):2287-97. PubMed ID: 1421400
[TBL] [Abstract][Full Text] [Related]
48. Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.
Heerema NA; Byrd JC; Dal Cin PS; Dell' Aquila ML; Koduru PR; Aviram A; Smoley SA; Rassenti LZ; Greaves AW; Brown JR; Rai KR; Kipps TJ; Kay NE; Van Dyke DL;
Cancer Genet Cytogenet; 2010 Dec; 203(2):134-40. PubMed ID: 21156225
[TBL] [Abstract][Full Text] [Related]
49. Transitional B Cells and TLR9 Responses Are Defective in Selective IgA Deficiency.
Lemarquis AL; Einarsdottir HK; Kristjansdottir RN; Jonsdottir I; Ludviksson BR
Front Immunol; 2018; 9():909. PubMed ID: 29755476
[TBL] [Abstract][Full Text] [Related]
50. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
Schuler M; Tretter T; Schneller F; Huber C; Peschel C
Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
[TBL] [Abstract][Full Text] [Related]
51. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.
Secchiero P; Melloni E; Tiribelli M; Gonelli A; Zauli G
J Leukoc Biol; 2008 Feb; 83(2):434-7. PubMed ID: 17998303
[TBL] [Abstract][Full Text] [Related]
52. Analysis of somatic hypermutations in the IgM switch region in human B cells.
Horiuchi K; Imai K; Mitsui-Sekinaka K; Yeh TW; Ochs HD; Durandy A; Nonoyama S
J Allergy Clin Immunol; 2014 Aug; 134(2):411-9. PubMed ID: 24836470
[TBL] [Abstract][Full Text] [Related]
53. B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro.
Malisan F; Fluckiger AC; Ho S; Guret C; Banchereau J; Martinez-Valdez H
Blood; 1996 Jan; 87(2):717-24. PubMed ID: 8555496
[TBL] [Abstract][Full Text] [Related]
54. Morphology and expression status investigations of specific surface markers on B-cell chronic lymphocytic leukemia cells.
Niu S; Chan R; Berini P; Wang C; Zou S
Microsc Res Tech; 2013 Nov; 76(11):1147-53. PubMed ID: 23963997
[TBL] [Abstract][Full Text] [Related]
55. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
56. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
57. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
[TBL] [Abstract][Full Text] [Related]
58. Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides.
Decker T; Hipp S; Kreitman RJ; Pastan I; Peschel C; Licht T
Blood; 2002 Feb; 99(4):1320-6. PubMed ID: 11830482
[TBL] [Abstract][Full Text] [Related]
59. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation.
Oppezzo P; Vuillier F; Vasconcelos Y; Dumas G; Magnac C; Payelle-Brogard B; Pritsch O; Dighiero G
Blood; 2003 May; 101(10):4029-32. PubMed ID: 12521993
[TBL] [Abstract][Full Text] [Related]
60. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
Ranheim EA; Cantwell MJ; Kipps TJ
Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
